Flotation/IPO

Metromile makes tracks to reverse merger
The Mitsui, China Pacific, AmTrust, Tokio Marine and Intact Financial-backed automotive insurer is teaming with Insu Acquisition Corp. II to form a business with a $1.3bn valuation.
Ozon to float in $990m IPO
Sistema invested $67.5m in the e-commerce platform developer alongside an upsized initial public offering in which it floated above its range.
Butterfly Network lands on reverse merger
The Fosun-backed ultrasound scanner provider will take Longview Acquisition Corp's NYSE spot, with the combined company to be valued at $1.5bn.
Wish looks to dish up $1bn IPO
JD.com-backed mobile commerce platform Wish has filed to go public a little over a year after raising money at an $11.2bn valuation.
Antengene accelerates to $360m flotation
The WuXi AppTec, Celgene, Taikang and Tigermed-backed cancer drug developer went public in Hong Kong at the top of its range.
GenCell powers its way to public markets
TDK Ventures, Paz Oil and Landa Ventures-backed hydrogen and ammonia fuel cell technology developer raised $60.7m in an Israel flotation.
Roblox readies billion-dollar IPO
Game creation platform developer Roblox has filed for a $1bn offering that will come after $500m in funding from investors including Tencent.
NeoGames passes IPO level
William Hill sold $11.5m shares in the $81.7m initial public offering but remains the lottery software producer's largest shareholder.

Other News

Arrival plugs into reverse merger deal
Hyundai, Kia and UPS will retain stakes in the electric vehicle developer, which is merging with publicly-listed CIIG Merger Corp at a $5.4bn combined valuation.
4DMT retries IPO with $75m filing
Pfizer Ventures and Chiesi Ventures-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.
Supcon to succeed with $268m IPO
Chint, Sinopec, Intel, Wanxiang and Lenovo-backed process automation technology producer Supcon has priced an offering on Shanghai's Star Exchange.
Airbnb aims for $1bn in IPO
CapitalG-backed short-term accommodation provider Airbnb last raised financing at a $1bn pre-money valuation in April.
Sigilon signals $100m IPO target
Chronic illness drug developer Sigilon Therapeutics has filed to go public after raising almost $200m from investors including Eli Lilly.
BioAtla bids for public markets spot
Pfizer Ventures is the largest individual shareholder in the cancer therapeutics developer, which has filed for a $100m offering.

Editor's Picks

Wish looks to dish up $1bn IPO
JD.com-backed mobile commerce platform Wish has filed to go public a little over a year after raising money at an $11.2bn valuation.
Airbnb aims for $1bn in IPO
CapitalG-backed short-term accommodation provider Airbnb last raised financing at a $1bn pre-money valuation in April.
Ant Group blocked from $34bn IPO
Chinese regulators have suspended the Alibaba spinoff's initial public offering, which was set to value the financial services provider at $313bn.
Lufax loops on to public markets
Ping An's financial services spinoff raised $2.36bn in a US initial public offering that represented an exit for Bank of China, Cofco, SBI and several investment banks.
test reg

Login